|
Aug 4
|
AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
|
|
Aug 4
|
IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
|
|
Aug 4
|
Boston Scientific Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 1
|
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
|
|
Aug 1
|
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
|
|
Aug 1
|
GEHC vs. BSX: Which Stock Is the Better Value Option?
|
|
Aug 1
|
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
|
|
Aug 1
|
Boston Scientific Stock Outlook: Is Wall Street Bullish or Bearish?
|
|
Aug 1
|
Stryker lowers expected tariff impact to $175M
|
|
Aug 1
|
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
|
|
Jul 31
|
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
|
|
Jul 31
|
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
|
|
Jul 31
|
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
|
|
Jul 31
|
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
|
|
Jul 31
|
ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down
|
|
Jul 31
|
Hologic Stock Falls Despite Q3 Earnings and Revenue Beat, Margins Down
|
|
Jul 31
|
These 4 Measures Indicate That Boston Scientific (NYSE:BSX) Is Using Debt Safely
|
|
Jul 30
|
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
|
|
Jul 30
|
GE HealthCare raises annual profit forecast on smaller tariff impact
|
|
Jul 30
|
Australia Anti-Venom Market Analysis Report 2025-2033 Featuring BSV, Boehringer Ingelheim, Boston Scientific, CSL, Merck, Pfizer, Haffkine Bio-Pharmaceutical
|